No presentations found
We’ll display presentations we find for VISEN Pharmaceuticals here
𝛼SK or SearchENTITY
VISEN Pharmaceuticals (2561 HK)
VISEN Pharmaceuticals (2561 HK)
14
Analysis
Health Care • China
VISEN Pharmaceuticals is an innovative biopharmaceutical company focused on endocrine diseases. It develops and commercializes therapies for conditions such as pediatric growth hormone deficiency, achondroplasia, and chronic hypoparathyroidism. The company was founded in 2018 and is headquartered in Suzhou, China.
morex